about
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levelsMeta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseAssociation analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistanceGenome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1Methylation alterations are not a major cause of PTTG1 misregulation.Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.Genetic structure of the Spanish population."Does replication groups scoring reduce false positive rate in SNP interaction discovery? Response".ATP5H/KCTD2 locus is associated with Alzheimer's disease risk.Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA)WWOX gene is associated with HDL cholesterol and triglyceride levels.A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysis.Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.Exploratory analysis of seven Alzheimer's disease genes: disease progressionSpecific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volumeGenetic analysis of the GRM1 gene in human melanoma susceptibility.Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.Pharmacogenetics of controlled ovarian hyperstimulation.CCR5 expression influences the progression of human breast cancer in a p53-dependent mannerBeneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.The therapeutic potential of the calpain family: new aspects.Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.Gut ammonia production and its modulation.Genetic and genomic insights into age at natural menopausePharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.Genome research in pre-dementia stages of Alzheimer's disease.Frontotemporal Lobar Degeneration. Review and update for clinical neurologists.Assessing the role of TUBA4A gene in frontotemporal degeneration.Genetic risk for schizophrenia and psychosis in Alzheimer disease.CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.Impact of Recruitment Methods in Subjective Cognitive Decline.Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7].The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke.
P50
Q21261445-9684E9A0-1258-4578-BCC4-A85965FB279EQ22251067-7EE06D40-E8D8-44A1-ABA4-A1762614DB37Q28478002-1B1DB671-6882-471B-AF1C-F392B6C1FB1AQ28730143-7DC515B5-C184-4135-893F-A8056B43B33AQ33329701-D44CE1A9-DD82-4B24-9B4C-134528FFE6ECQ33350754-B2C1F920-F00E-4B28-9F81-F951E78E5906Q33586898-9C452ECF-AC55-445C-B35E-846BC8D37704Q33615229-7588F536-849F-4DAB-9A71-3674D4D62704Q33652534-E28BD9B0-5523-45B3-B10E-3C0AD3B2D785Q33691016-CB2D815E-6D98-4655-A1B2-138118C3883BQ33717629-E22EA3B2-7F9C-414A-AFD4-F47237553C3BQ33825967-B5242440-8DBB-418D-B954-71894C8482A4Q33837891-C35A6FF8-3B43-434B-B12B-8EB40415708CQ33897884-D8D1708B-D6C7-4F8E-AE52-25FAD4F4AE46Q34482154-39BD1EC6-C96D-41B4-A4BE-4875BCB69411Q34630564-650DB22D-4425-4992-A876-06130DF6F1F6Q34645746-3D2D06C0-47ED-46E7-A0CB-C8E3FEBC5B4DQ35022765-E5CDEB90-E01D-4603-A7A5-06CBA5776AAAQ36249242-D7054E23-B808-4B5C-8DA0-8B5D1B99B7D7Q36371823-E14DDEAA-C9E9-406C-8270-CFAB368A4A02Q36555729-A089CEBB-559B-4913-906E-6FB205EF8384Q36573598-554776FC-9796-47BB-8B03-1723B8C6E6D5Q36601917-239F61F2-80CB-4EDA-A25C-89BEE48E97E0Q36856535-D80CDAC2-196D-4974-BBEC-8F873E9916E8Q37344744-9688981A-167D-49C1-B2C5-472232ED4B58Q37402602-739DFB34-D2DB-462F-B94E-3C4DF2723CF7Q37814403-0FF1E505-2386-4253-97F2-7ECBBA60212DQ38847374-DC0DE883-282B-48EB-AC00-FDD22983689FQ39459043-619A76D1-A952-4AE6-B61C-67DD76DF862DQ40203553-44D7E218-CF92-4BAF-B268-8A5AE917D7CEQ40219679-2769F468-5FAF-4249-A1E4-83B06F8F5253Q43158556-75D70793-636F-4250-987C-5DD7A8B48A15Q44074071-BCD42EFA-FB90-4B7B-9446-5D110CA0F0C5Q45236056-1131EB6D-12E6-425F-BE47-7DDAEB7ED406Q47952621-91135297-15AF-46B4-994A-BA86192991FBQ48090963-9DFF94D1-8347-4A4C-B630-A6FE26B1D422Q48520500-75CEC925-CEC9-45B8-8D8A-AB710E27F25AQ50085323-50348665-DF11-4E5D-9E71-13A7FB805D7EQ50534625-BCD6F9C0-DABD-4126-A514-34E55FBA1F44Q50763838-6767BB3A-2167-4DEB-A3EE-65E5EB3A3FCA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Agustín Ruíz
@en
Agustín Ruíz
@nl
type
label
Agustín Ruíz
@en
Agustín Ruíz
@nl
prefLabel
Agustín Ruíz
@en
Agustín Ruíz
@nl
P31
P496
0000-0003-2633-2495